Publications Office of the EU
Acquisition of factor preparations - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Acquisition of factor preparations Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    02/01/2025
  • Deadline
    08/01/2025
  • Today
    23/01/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
Yes
Buyer
Nemzeti Egészségbiztosítási Alapkezelő
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: HU110 Budapest
Business sector (Main CPV)
33621200 Antihaemorrhagics
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
4
Procedure details
Tender reference number
EKR002279132024
Description

Acquisition of factor preparations for the treatment of congenital haemorrhage by 31 December 2026 through an accelerated negotiated procedure with a view to concluding a framework agreement in four parts. Where there are several strengths for the medicinal product in question, the contracting authority shall require that the offer be made for each strength. Part 1: natural, chemically unmodified 4th generation B-domain abbreviated factor VIII concentrate (ATC code: B02BD02)): 20 000 000 IU (and the quantity of prisoners required: 11 200 000 IU); Part 2: emicizumab (a monoclonal antibody used to treat patients with an inhibitor of FVIII) (ATC code: B02BX06): 150 000 mg (and mandatory quantity of rabatt: 21 420 mg ; Part 3: reptacog alfa (activated) (recombinant activated coagulation factor VII) (ATC code: B02BD08): 32 000 mg (and mandatory quantity of rabatt: 2600 mg); Part 4: activated prothrombin complex concentrate (preparation with coagulation factor VIII inhibitor bypassing activity) (ATC code: B02BD03): 11 000 000 IU (and the quantity of prisoners required: 1 100 000 IU) A 16/2012. (II. 16.) on the basis of Section 14(1) of the Government Decree on the Public Procurement Act. The risks associated with treatment with a medicinal product or a medical device, in particular the varying number of patients in need of treatment or their urgent need for care, as well as changes in the distribution of medicinal products and medical devices to be purchased due to unforeseen reasons, shall be regarded as circumstances under Section 85(2)(c). In the present case, there is an urgent need for patient care which, on the basis of the Government Decree and the provisions of the Public Procurement Act cited above, confirms the legal basis of the negotiated procedure and the accelerated nature of the procedure. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://ekr.gov.hu/portal/kozbeszerzes/eljarasok/EKR002279132024/reszletek
Tenders may be submitted
Electronic submission: required
https://ekr.gov.hu/portal/kozbeszerzes/eljarasok/EKR002279132024/reszletek
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
HU Magyarország
HUZZZ Extra-Regio NUTS 3
CPV code

33621200 - Antihaemorrhagics

33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated

Lots (4)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.